Rocket Lab jumps ~6% as iQPS adds three Electron launches and bulls re-rate
Rocket Lab shares rose about 5.7% on April 16, 2026 to around $80 as investors bought after a fresh multi-launch expansion with Japan’s iQPS and renewed bullish analyst commentary. The move follows a newly signed contract for three additional dedicated Electron launches, extending iQPS’s manifest through 2028.
1. What’s moving the stock today
Rocket Lab (RKLB) is up about 5.7% on Thursday, April 16, 2026, trading near $80, as buyers react to incremental launch backlog growth and renewed positive sell-side framing. The key catalyst is a recently signed contract with Japan-based iQPS for three additional dedicated Electron missions, reinforcing Rocket Lab’s repeat-customer momentum and improving launch visibility into the late-2020s.
2. The catalyst: iQPS adds three more Electron missions
iQPS disclosed on April 10, 2026 that it signed a new launch contract with Rocket Lab covering three additional QPS-SAR satellite launches. Market commentary around the deal emphasizes schedule control (dedicated launches) and higher predictability for Rocket Lab’s launch cadence, with the added missions pushing contracted activity further out on the manifest through 2028.
3. Why investors care: recurring customers and backlog durability
For Rocket Lab, repeat bookings help de-risk revenue timing in a launch market where customer concentration and schedule volatility can dominate sentiment. A multi-launch expansion also supports the narrative that Electron remains a relevant, premium offering for constellation operators that prioritize orbit and timing control—an angle that can matter as the company balances launch growth with its broader space-systems revenue base.
4. What to watch next
Investors will focus on (1) the timing of iQPS’s next Electron mission (widely discussed as no earlier than May 2026), (2) whether additional iQPS orders arrive as the SAR constellation scales, and (3) any updates to Neutron development and first-flight timing that could change medium-lift expectations. Near-term upside catalysts could include further contract wins, launch execution, and additional analyst price-target revisions tied to backlog conversion.